Evidence map›Paper›PMID 41636518›Full record

ArticlemBio2026

HIV-1 Vpr induces an NFAT-controlled transcriptional program in primary CD4+ T cells.

Johanna Leyens, Carlos Alberto Vanegas-Torres, Anthea Darius, Rabea Seizer, Brigitta Maurer, Daniel Sauter, Rishikesh Lotke, Michael Schindler

Abstract read
In one paragraph

Article in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Johanna Leyens *Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, Tübingen, Germany.ORCID 0009-0009-1689-4751
Carlos Alberto Vanegas-Torres *Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, Tübingen, Germany.
Anthea Darius *Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, Tübingen, Germany.
Rabea SeizerInstitute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, Tübingen, Germany.
Brigitta MaurerInstitute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, Tübingen, Germany.
Daniel SauterInstitute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, Tübingen, Germany.ORCID 0000-0001-7665-0040
Rishikesh LotkeInstitute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, Tübingen, Germany.
Michael SchindlerInstitute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, Tübingen, Germany.ORCID 0000-0001-8989-5813

Funding

Deutsche Forschungsgemeinschaft SA 2676/3-1Deutsche Forschungsgemeinschaft SCHI 1073/7-2
6 · The paper itself

Abstract

HIV-1 Vpr has a major impact on the cellular transcriptome and proteome. Although Vpr is known to stimulate the nuclear factor of activated T cells (NFAT), it remained unclear to what extent transcriptional changes induced by Vpr are governed by NFAT. We, therefore, performed RNA sequencing and transcription factor network analyses of primary CD4+ T cells infected with HIV-1 harboring an intact or defective IMPORTANCE: The HIV-1 accessory protein Vpr is known for its profound effect on the host proteome. It degrades many cellular proteins, including transcription factors and DNA-associated proteins. In addition, Vpr activates the nuclear factor of activated T cells (NFAT), a key transcription factor in T cells. However, it has remained unclear to what extent Vpr and consequently NFAT control changes in the transcriptome of HIV-1-infected primary CD4+ T cells. In this study, we show that Vpr significantly alters the transcriptome of CD4+ T cells, with almost half of the deregulated genes being under NFAT control. These changes involve pathways associated with increased immune activation and cell cycle regulation, shedding light on how Vpr contributes to CD4+ T cell depletion and HIV-1 pathogenesis.

Indexed as

CD4-Positive T-LymphocytesGene Expression RegulationHIV-1Host-Pathogen InteractionsNFATC Transcription Factorsvpr Gene Products, Human Immunodeficiency VirusAntigens, CDAntigens, Differentiation, T-LymphocyteCD69 AntigensCells, CulturedGene Expression ProfilingHumansLectins, C-TypeLymphocyte ActivationAntigens, CDAntigens, Differentiation, T-LymphocyteCD69 AntigensLectins, C-TypeNFATC Transcription Factorsvpr Gene Products, Human Immunodeficiency Virusvpr protein, Human immunodeficiency virus 1CD4+ T cellscell cycleG2 arrestHIV-1NFATtranscriptional networkVpr

Identifiers

PMID41636518
PMCPMC12977483

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.